T1	Participants 0 11	Multicenter
T2	Participants 108 140	advanced head and neck carcinoma
T3	Participants 368 442	advanced head and neck squamous cell carcinoma or nasopharyngeal carcinoma
T4	Participants 458 554	locally advanced or metastatic head and neck squamous cell carcinoma or nasopharyngeal carcinoma
T5	Participants 730 797	One hundred and thirty-six eligible patients were randomly assigned
T6	Participants 1580 1654	advanced head and neck squamous cell carcinoma or nasopharyngeal carcinoma
